Exploring patient experience of facial nerve palsy to inform the development of a PROM

Plastic and Reconstructive Surgery - Global Open

Volumn 7, Issue 1, 2019, Pages

  Norris, Jonathan H ^a   Longmire, Natasha M ^b   Kilcoyne, Sarah ^c   Johnson, David ^c   Fitzpatrick, Ray ^d   Klassen, Anne F ^b  

^a OXFORD EYE HOSPITAL   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d NUFFIELD COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85064860543     PISSN: None     EISSN: 21697574     Source Type: Journal    
DOI: 10.1097/GOX.0000000000002072     Document Type: Article

References (42)

1. Rowlands S, Hooper R, Hughes R, et al. The epidemiology and treatment of Bell's palsy in the UK. Eur J Neurol. 2002;9:63-67.
2. Benecke JE Jr. Facial paralysis. Otolaryngol Clin North Am. 2002;35:357-365.
3. Shindo M. Management of facial nerve paralysis. Otolaryngol Clin North Am. 1999;32:945-964.
4. Schrom T, Buchal A, Ganswindt S, et al. Patient satisfaction after lid loading in facial palsy. Eur Arch Otorhinolaryngol. 2009;266:1727-1731.
5. Ciuman RR, Oels W, Jaussi R, et al. Outcome, general, and symptom-specific quality of life after various types of parotid resection. Laryngoscope. 2012;122:1254-1261.
6. VanSwearingen JM, Cohn JF, Turnbull J, et al. Psychological distress: linking impairment with disability in facial neuromotor disorders. Otolaryngol Head Neck Surg. 1998;118:790-796.
7. Nightingale F. Some Notes on Hospitals. 3rd ed. London, United Kingdom: Longmans, Green and Co; 1863.
8. Cano SJ, Klassen A, Pusic AL. The science behind quality-of-life measurement: a primer for plastic surgeons. Plast Reconstr Surg. 2009;123:98e-106e.
9. World Health Organization. Basic Documents. 48th ed. [online]. 2014. Available at http://apps. who. int/gb/bd/PDF/bd48/basicdocuments-48th-edition-en. pdf#page=7. Accessed August 31, 2016.
10. US Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. [online]. 2009. Available at http://www. fda. gov/downloads/Drugs/... /Guidances/UCM193282. pdf. Accessed February 1, 2016.
11. Department of Health. Guidance on the routine collection of patient reported outcome measures (PROMs). [online]. 2009. Available at http://webarchive. nationalarchives. gov. uk/20130107105354/ http://www. dh. gov. uk/prod-consum-dh/groups/dh-digitalassets/@ dh/@en/documents/digitalasset/dh-092625. pdf. Accessed May 4, 2016.
12. Baumhauer JF, Bozic KJ. Value-based healthcare: PROs in clinical decision-making. Clin Orthop Relat Res. 2016;474:1375.
13. Nelson EC, Eftimovska E, Lind C, et al. Patient reported outcome measures in practice. BMJ. 2015;350:g7818.
14. Scientific Advisory Committee of the Medical Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205.
15. Wu AW, Kharrazi H, Boulware LE, et al. Measure once, cut twice-adding PROs to the electronic health record for comparative effectiveness research. J Clin Epidemiol. 2013;203;66:S12.
16. Ho AL, Scott AM, Klassen AF, et al. Measuring quality of life and patient satisfaction in facial paralysis patients: a systematic review of patient-reported outcome measures. Plast Reconstr Surg. 2012;130:91-99.
17. Fattah AY, Gavilan J, Hadlock TA, et al. Survey of methods of facial palsy documentation in use by members of the Sir Charles Bell Society. Laryngoscope. 2014;124:2247-2251.
18. VanSwearingen JM, Brach JS. The facial disability index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996;76:1288-1298; discussion 1298.
19. Kahn JB, Gliklich RE, Boyev KP, et al. Validation of a patientgraded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope. 2001;111:387-398.
20. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass.: New England Medical Center, The Health Institute; 1993.
21. Robinson K, Gatehouse S, Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol. 1996;105:415-422.
22. Lee EH, Klassen AF, Lawson JL, et al. Patient experiences and outcomes following facial skin cancer surgery: a qualitative study. Australas J Dermatol. 2016;57:e100-e104.
23. Klassen AF, Cano SJ, Scott A, et al. Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q. Facial Plast Surg. 2010;26:303-309.
24. Thorne SE. Interpretive Description. Developing Qualitative Inquiry. Walnut Creek, Calif.: Left Coast Press; 2008.
25. Brooker J, Burney S, Fletcher J, et al. A qualitative exploration of quality of life among individuals diagnosed with an acoustic neuroma. Br J Health Psychol. 2009;14:563-578.
26. Alicandri-Ciufelli M, Piccinini A, Grammatica A, et al. A step backward: the 'Rough' facial nerve grading system. J Craniomaxillofac Surg. 2013;41:e175-e179.
27. Banks CA, Jowett N, Hadlock CR, et al. Weighting of facial grading variables to disfigurement in facial palsy. JAMA Facial Plast Surg. 2016;18:292-298.
28. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93:146-147.
29. Katsumi S, Esaki S, Hattori K, et al. Quantitative analysis of facial palsy using a three-dimensional facial motion measurement system. Auris Nasus Larynx. 2015;42:275-283.
30. Kecskés G, Jóri J, O'Reilly BF, et al. Clinical assessment of a new computerised objective method of measuring facial palsy. Clin Otolaryngol. 2011;36:313-319.
31. Lee LN, Susarla SM, H Hohman M, et al. A comparison of facial nerve grading systems. Ann Plast Surg. 2013;70:313-316.
32. Lassaletta L, Alfonso C, Del Rio L, et al. Impact of facial dysfunction on quality of life after vestibular schwannoma surgery. Ann Otol Rhinol Laryngol. 2006;115:694-698.
33. Nicoucar K, Momjian S, Vader JP, et al. Surgery for large vestibular schwannomas: how patients and surgeons perceive quality of life. J Neurosurg. 2006;105:205-212.
34. Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebocontrolled trial using subjective endpoints. Plast Reconstr Surg. 2005;116:36-43.
35. Walker DT, Hallam MJ, Ni Mhurchadha S, et al. The psychosocial impact of facial palsy: our experience in one hundred and twenty six patients. Clin Otolaryngol. 2012;37:474-477.
36. Lansdown R, Rumsey N, Bradbury E, et al. Visibly Different: Coping with Disfigurement. Oxford, United Kingdom: Butterworth-Heinemann; 1997.
37. Department of Health. Transparency in outcomes-a framework for the NHS. [online]. 2010. Available at http://webarchive. nationalarchives. gov. uk/+/www. dh. gov. uk/prod-consum-dh/ groups/dh-digitalassets/@dh/@en/documents/digitalasset/ dh-122952. pdf. Accessed May 4, 2016.
38. Pusic AL, Klassen AF, Scott AM, et al. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124:345-353.
39. Klassen AF, Cano SJ, Alderman A, et al. The BODY-Q: a patientreported outcome instrument for weight loss and body contouring treatments. Plast Reconstr Surg Glob Open. 2016;4:e679.
40. Luo Y, Yang J, Zhang Y. Development and validation of a patientreported outcome measure for stroke patients. Health Qual Life Outcomes. 2015;13:53.
41. Klassen AF, Cano SJ, Schwitzer JA, et al. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg. 2015;135:375-386.
42. Oliffe J, Thorne S. Men, masculinities, and prostate cancer: Australian and Canadian patient perspectives of communication with male physicians. Qual Health Res. 2007;17:149-161.